Details for New Drug Application (NDA): 210179
✉ Email this page to a colleague
The generic ingredient in CARMUSTINE is carmustine. There are eleven drug master file entries for this compound. Twelve suppliers are listed for this compound. Additional details are available on the carmustine profile page.
Summary for 210179
Tradename: | CARMUSTINE |
Applicant: | Navinta Llc |
Ingredient: | carmustine |
Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 210179
Suppliers and Packaging for NDA: 210179
Tradename | Generic Name | Dosage | NDA | Application Type | Supplier | National Drug Code | Package Code | Package |
---|---|---|---|---|---|---|---|---|
CARMUSTINE | carmustine | INJECTABLE;INJECTION | 210179 | ANDA | Navinta LLC | 68475-503 | 68475-503-01 | 1 KIT in 1 CARTON (68475-503-01) * 3 mL in 1 VIAL (68475-502-01) * 30 mL in 1 VIAL, SINGLE-DOSE (68475-500-01) |
CARMUSTINE | carmustine | INJECTABLE;INJECTION | 210179 | ANDA | Zydus Pharmaceuticals USA Inc. | 70710-1525 | 70710-1525-9 | 1 KIT in 1 CARTON (70710-1525-9) * 3 mL in 1 VIAL (70710-1523-1) * 30 mL in 1 VIAL, SINGLE-DOSE (70710-1524-1) |
Profile for product number 001
Active Rx/OTC/Discontinued: | RX | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/VIAL | ||||
Approval Date: | Sep 11, 2018 | TE: | AP | RLD: | No |
Complete Access Available with Subscription